Joseph Group Capital Management Buys 2,317 Shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP)

Joseph Group Capital Management boosted its position in shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP) by 15.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 17,397 shares of the company’s stock after acquiring an additional 2,317 shares during the period. Joseph Group Capital Management owned approximately 0.51% of Invesco Pharmaceuticals ETF worth $1,437,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in PJP. FMR LLC increased its position in shares of Invesco Pharmaceuticals ETF by 29.4% during the third quarter. FMR LLC now owns 1,057 shares of the company’s stock valued at $92,000 after purchasing an additional 240 shares during the period. Jones Financial Companies Lllp increased its holdings in Invesco Pharmaceuticals ETF by 195.7% in the 4th quarter. Jones Financial Companies Lllp now owns 2,176 shares of the company’s stock valued at $180,000 after buying an additional 1,440 shares during the period. JPMorgan Chase & Co. raised its stake in shares of Invesco Pharmaceuticals ETF by 241.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,046 shares of the company’s stock valued at $352,000 after buying an additional 2,862 shares in the last quarter. Grimes & Company Inc. bought a new position in shares of Invesco Pharmaceuticals ETF during the 4th quarter worth about $354,000. Finally, Arete Wealth Advisors LLC acquired a new stake in shares of Invesco Pharmaceuticals ETF during the 3rd quarter valued at about $402,000.

Invesco Pharmaceuticals ETF Stock Down 0.2 %

NYSEARCA PJP opened at $84.23 on Friday. Invesco Pharmaceuticals ETF has a twelve month low of $75.33 and a twelve month high of $89.87. The stock has a market cap of $255.22 million, a P/E ratio of 21.82 and a beta of 0.56. The company’s 50-day simple moving average is $85.66 and its 200 day simple moving average is $85.70.

Invesco Pharmaceuticals ETF Increases Dividend

The business also recently announced a dividend, which was paid on Friday, March 28th. Stockholders of record on Monday, March 24th were issued a $0.2729 dividend. The ex-dividend date of this dividend was Monday, March 24th. This is a boost from Invesco Pharmaceuticals ETF’s previous dividend of $0.21.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.